--- title: "Chainalysis vs Elliptic vs TRM Labs: Choosing Blockchain Analytics in 2026" slug: blockchain-analytics-providers-compared publishedAt: 2026-05-03T09:00:00Z author: Finconduit Editorial Team tags: MiCA, TFR, FATF canonicalUrl: https://finconduit.com/resources/blockchain-analytics-providers-compared --- # Chainalysis vs Elliptic vs TRM Labs: Choosing Blockchain Analytics in 2026 The three dominant blockchain analytics providers for regulated CASPs compared — chain coverage, attribution depth, investigations, sanctions, pricing, and which vendor fits which CASP profile. Blockchain analytics is no longer optional for a regulated **CASP** — the [Markets in Crypto\-Assets Regulation](https://eur-lex.europa.eu/eli/reg/2023/1114/oj) authorisation file requires evidence of operational analytics capability with a named provider, the [Transfer of Funds Regulation](https://eur-lex.europa.eu/eli/reg/2023/1113/oj) requires risk\-based screening on every transfer above €1,000 to and from self\-hosted wallets, and the [EBA Guidelines](https://www.eba.europa.eu/) treat crypto\-specific typologies \(mixers, peel chains, privacy coins\) as standing enhanced\-due\-diligence triggers. Three vendors dominate the market for serious **CASP**s in 2026: **Chainalysis**, **Elliptic**, and **TRM Labs**.¹[^1]³[^2]⁴[^3] Each takes a different posture. **Chainalysis** is the incumbent with the **broadest** enterprise deployment, the **deepest** **investigations** product \(Reactor\), and the **highest** list price. **Elliptic** is the European\-headquartered alternative with strong regulator relationships, particularly across the **FCA** / EEA NCA pipeline, and historical strength in **MiCA**\-era authorisation files. **TRM Labs** is the newer entrant that has scaled aggressively with attribution depth on EVM and **Solana** ecosystems and a growing institutional base. This guide compares the three head\-to\-head: chain coverage, attribution depth, screening **API** performance, **investigations** product, sanctions handling, integration complexity, pricing, and which vendor fits which **CASP** profile. The headline: most large **CASP**s run two providers in parallel — typically **Chainalysis** as the primary **investigations** stack with **Elliptic** or **TRM Labs** as the screening and overlap detection layer. Sole\-vendor architectures are increasingly the exception. ## Why Blockchain Analytics Is Mandatory In 2026 Five regulatory drivers force **blockchain analytics** into every regulated crypto stack. Each one alone would justify the spend; together they make sole\-source crypto operations effectively impossible to defend at supervisory inspection. - **MiCA** authorisation. NCAs require evidence of an analytics provider contract and integration architecture in the Programme of Operations. - **TFR** **Travel Rule** self\-hosted wallet workflow. Risk\-based **EDD** on transfers ≥ €1,000 to/from non\-custodial wallets requires **address attribution** and risk scoring. - Source of funds at onboarding. **CDD** policies require provenance assessment of inbound crypto deposits — analytics provides the evidence. - Sanctions screening. [Office of Foreign Assets Control](https://ofac.treasury.gov/) SDN list now contains crypto wallet addresses \(Tornado Cash, Garantex, Lazarus Group, Hydra successors\) — **sanctions screening** at the wallet level requires analytics.⁶[^4] - [Sixth Anti\-Money Laundering Directive](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32018L1673) predicate offences. Investigation of suspected ML requires forensic tools to trace funds across hops, chains, and bridges. Without analytics, the **investigation** product is non\-existent.⁷[^5] > **Warning:** 'In\-house analytics' as a primary control fails first review. Several CASPs argue that internal blockchain monitoring is sufficient. NCAs treat this as a red flag — the cost of building real attribution data \(clustering across millions of addresses, sanctions list integration, attribution metadata\) is materially above the price of any vendor contract. Build internally for differentiation, not for compliance baseline. ## Side\-by\-Side Provider Comparison The three providers diverge most across attribution depth on long\-tail chains, **investigations** product strength, and pricing. The table below benchmarks each on the dimensions that actually drive procurement decisions. *Table: Chainalysis vs Elliptic vs TRM Labs — comparison across the dimensions that drive CASP procurement \(2026\).* | Dimension | Chainalysis | Elliptic | TRM Labs | | --- | --- | --- | --- | | HQ / domicile | USA \(NYC\) | UK \(London\) | USA \(San Francisco\) | | Founded | 2014 | 2013 | 2018 | | Chain coverage | 200\+ chains | 100\+ chains, deep on majors | 150\+ chains, strong on EVM \+ Solana | | Attribution depth \(BTC/ETH\) | Industry leader | Comparable to Chainalysis | Comparable; faster updates on new entities | | Attribution depth \(long\-tail chains\) | Strong everywhere | Selective by chain | Particularly strong on Solana, Tron, Polygon | | Wallet screening API \(real\-time\) | Chainalysis KYT — sub\-second | Elliptic Lens — sub\-second | TRM Wallet Screening — sub\-second | | Investigations product | Chainalysis Reactor — industry standard | Elliptic Investigator — strong, slightly less feature\-rich | TRM Investigations \+ Tactical — fast\-improving | | Sanctions integration | OFAC \+ EU \+ UK \+ Canada \+ Japan native | OFAC \+ EU \+ UK native; broad coverage | OFAC \+ EU native; growing list | | Travel Rule integration | Partner: Notabene primary | Partner: Notabene \+ native lookup | Partner: TRM\-native for Veriscope | | EEA regulatory presence | Deployed across LT, IE, MT, CY, DE | Strong; particularly UK and CY | Growing fast; institutional skewed | | Annual cost \(mid\-sized CASP\) | €120,000–€250,000 | €80,000–€180,000 | €60,000–€150,000 | | Implementation time | 6–10 weeks | 4–8 weeks | 4–8 weeks | | Best for | Large CASPs needing investigations depth | EEA\-regulated CASPs prioritising regulator relationship | EVM/Solana\-heavy CASPs, fast\-moving teams | ## **Chainalysis** — The Investigations Incumbent **Chainalysis** is the most\-deployed **blockchain analytics** platform across regulated crypto firms globally. **Coinbase**, **Kraken**, **Binance** entities, **Bitstamp** and the majority of Tier\-1 EU exchanges run **Chainalysis** as either primary or one of two providers. The product suite — **Chainalysis KYT** for **real\-time** **wallet screening**, Reactor for **investigations**, and Crypto Investigations Solutions for forensic case management — is the industry standard. **Chainalysis**'s structural advantage is attribution data: 15\+ million labelled clusters, deep history on **BTC**, **ETH**, and major altcoins, and continuous attribution work on emerging entities \(sanctioned addresses, ransomware groups, exchange hot wallets\). Reactor's **investigation** flow is the benchmark — the tool every other vendor's product is compared against. The trade\-off is price. **Chainalysis** is the **highest**\-priced of the three at **€120,000**–**€250,000**/year for a mid\-sized **CASP**, with negotiation room mainly through volume tier commitments. The cost is justified for any **CASP** whose Reactor usage is material; for screening\-only deployments at smaller volumes, **Elliptic** or **TRM Labs** are typically more cost\-effective. ## **Elliptic** — The Regulator\-Engaged European Choice **Elliptic** is the European\-domiciled alternative with strong roots in EEA and UK regulator relationships. The **FCA**'s typology work has historically been informed by **Elliptic**; the **EBA Guidelines** on crypto\-specific ML/TF typologies reflect concepts \(peel chains, hop analysis\) that **Elliptic** helped popularise. **Elliptic Investigator** and Lens together cover the full screening\-and\-**investigation** workflow. **Elliptic**'s strengths: strongest UK / EEA regulator engagement, comparable **BTC** and **ETH** attribution to **Chainalysis**, slightly leaner **investigations** product, and pricing 30–40% below **Chainalysis**'s at the mid\-tier. The trade\-off: chain coverage is narrower than **Chainalysis**, particularly on long\-tail **Solana**, Tron, and emerging EVM L2 chains, and the **investigations** UX is functional rather than industry\-leading. **Elliptic** is the right choice for any EEA\-regulated **CASP** whose primary **AML** use case is screening \+ occasional **investigations**, where **Chainalysis**'s premium is hard to justify, and where the home NCA's familiarity with the vendor matters in supervisory dialogue. ## **TRM Labs** — The Fast\-Scaling Challenger **TRM Labs** is the youngest of the three \(founded 2018\) and has scaled aggressively, particularly through US institutional and law\-enforcement deployments. The product portfolio — **TRM Wallet Screening**, **TRM Investigations**, **TRM Tactical** for law enforcement — covers the full workflow with strong attribution velocity \(faster updates on emerging sanctioned addresses than the incumbents\). TRM's strengths: best\-in\-class attribution depth on **Solana**, Tron, and **Polygon** ecosystems; particularly strong on stablecoin flow tracing \(**USDT**, **USDC**\) which matters disproportionately for institutional **CASP**s; growing integration with **Notabene** and **Veriscope** for **Travel Rule** data exchange; and aggressive pricing — **€60,000**–€150,000/year for a mid\-sized **CASP**. Trade\-offs: smaller EEA regulator footprint than **Elliptic** \(though growing\), **investigations** product still maturing relative to **Chainalysis Reactor**, and the **BTC** attribution depth — while strong — has slightly less historical breadth than the incumbents. ## How to Choose — Decision Tree by **CASP** Profile There is no universal best provider. The right choice depends on volume, asset mix, jurisdiction, and whether **investigations** are a primary or supplementary use case. *Table: Blockchain analytics provider selection by CASP profile \(2026\).* | CASP profile | Recommended primary | Backup / supplement | | --- | --- | --- | | Large EEA CASP — investigations are core to ops | Chainalysis \(KYT \+ Reactor\) | TRM Labs as overlap / cost\-tier secondary | | Mid\-sized EEA CASP — screening primary, occasional investigations | Elliptic \(Lens \+ Investigator\) | Chainalysis Reactor for periodic deep\-dive cases | | EVM / Solana / stablecoin\-heavy CASP | TRM Labs \(stronger attribution on these chains\) | Chainalysis or Elliptic for BTC \+ cross\-asset coverage | | UK FCA\-authorised firm, regulator engagement matters | Elliptic \(strongest FCA relationship\) | Optional second provider | | Class 1 CASP \(advisory only, no client custody\) | Lightest\-touch — Elliptic at smallest tier | Optional Chainalysis trial via per\-query pricing | | Significant CASP \(ESMA\-supervised\) | Two providers minimum — Chainalysis \+ Elliptic OR Chainalysis \+ TRM | ESMA convergence expectations effectively require dual coverage | | Institutional / OTC desk with concentrated counterparty list | TRM Labs for stablecoin and fast attribution | Chainalysis Reactor on\-demand for investigations | | Stablecoin issuer \(EMT or ART\) | Chainalysis with full attribution \+ Reactor | TRM Labs for stablecoin\-specific tracing | > **Tip:** Most large CASPs run two providers in parallel. The marginal cost of the second contract is a fraction of the first — and the audit trail of having queried two independent attribution sources is materially stronger than relying on a single vendor's view of a borderline address. Plan for dual coverage from day one if your volume justifies €150,000\+ in primary spend. ## Implementation & Integration Implementation across all three providers follows similar shape: contract negotiation, sandbox, **API** integration into the deposit/withdrawal/onboarding flows, **MLRO** workflow training, and production cutover. The differences are in pace and depth. - Weeks 1–2: contract negotiation, NDAs, scoping workshops with the provider's solutions team. SLAs, **false\-positive rate** targets, and case\-management workflow defined. - Weeks 2–4: **API** integration. Wallet screening on inbound deposits and outbound withdrawals; risk\-score routing into the **transaction monitoring** system; **investigations** console access for the **MLRO** and **AML** team. - Weeks 4–6: **AML programme** update — risk\-scoring thresholds, escalation paths, case\-creation rules, false\-positive triage workflow. Document for NCA review. - Weeks 6–8: parallel run alongside any legacy screening. Compare hits, calibrate thresholds, finalise the production runbook. - Ongoing: monthly false\-positive review, quarterly relationship review with the provider, annual reconciliation of attribution coverage vs **CASP** customer geography. ## Common Implementation Pitfalls - Treating analytics as a checkbox. Authorisation files that name a vendor without evidence of operational integration are downgraded to high\-scrutiny review. - No documented escalation path for high\-risk hits. NCAs probe what happens after a **Chainalysis** or **TRM Labs** scoring threshold is breached — silent kills, account freezes, **MLRO** escalation must be documented. - Forgetting privacy coins and mixers. Most **CASP**s do not list Monero or Zcash, but they receive transfers from mixers \(Tornado Cash relays, peel\-chain endpoints\) constantly. Analytics rules must cover this typology, not just sanctioned\-address direct hits. - Failing to integrate analytics output into **transaction monitoring**. Risk scores must flow into the **AML** rules engine — not sit in a parallel console silo. - Underestimating false\-positive operational cost. A naive ruleset generates 5–10× the alert volume of a tuned one. Plan for 0.25–0.5 FTE of analyst time per provider per €1B annual volume. ## Frequently Asked Questions ### Do I need a **blockchain analytics** contract before **MiCA** authorisation? Yes. NCAs in **Lithuania**, **Cyprus**, **Ireland**, **Germany** and **Malta** all require evidence of an analytics provider contract and integration architecture in the authorisation file. 'We will procure post\-authorisation' is rejected on first review. Sign with one of **Chainalysis**, **Elliptic**, or **TRM Labs** before submission and document the integration in the Programme of Operations. ### Which provider is cheapest? **TRM Labs** has the **lowest** list price in the three at **€60,000**–€150,000/year for a mid\-sized **CASP**. **Elliptic** is mid\-tier at **€80,000**–**€180,000**. **Chainalysis** is the **highest** at **€120,000**–**€250,000**. But cheapest at the contract line is not always cheapest at the operational line — **Chainalysis Reactor** pays for itself if your **investigations** volume is meaningful; **TRM Labs**'s stablecoin attribution saves analyst time on **USDT**\-heavy flows. Match the price tier to your actual use case. ### Can I just use one provider? For a Class 1 or small Class 2 **CASP**, yes. For any **CASP** above €5B annual volume or with significant counterparty diversity, dual coverage is becoming the standard — and the **AMLA** / **ESMA** convergence push from 2027 will likely require it implicitly. Most large operators run two providers in parallel today. ### What happens when a provider misses a sanctioned address? All three providers rely on attribution data which is necessarily incomplete and time\-lagged. A newly\-sanctioned wallet may not appear on any provider's list for hours or days. The defensive posture: layer multiple sources, document the attribution latency in the **AML programme**, and update **OFAC** SDN screening separately from the provider's bundle. NCAs accept attribution latency as a fact of the technology — they do not accept absence of layered controls. ### How does the [AMLR](https://eur-lex.europa.eu/eli/reg/2024/1624/oj) / **AMLA** rollout from 2027 change vendor selection?⁵[^6] **AMLR** codifies common standards across the EU including expectations on **blockchain analytics** for crypto\-asset obliged entities. **AMLA**'s direct supervision of significant **CASP**s from 2028 will likely formalise dual\-provider expectations and potentially set common attribution standards. Any provider selection made today should anticipate stricter convergence within 24 months — favour vendors with strong **EBA**/**AMLA** engagement \(**Elliptic**, **Chainalysis** European subsidiaries\). ### Is in\-house analytics ever a viable substitute? Not for **compliance** baseline. Building credible attribution data — clustering across millions of addresses, integrating sanctions feeds, maintaining attribution metadata across hundreds of chains — costs €5M\+ per year and 12–18 months minimum to reach parity with a vendor product. In\-house tooling is valuable for firm\-specific differentiation \(proprietary risk models on top of vendor data, custom case workflows\) but should never replace a Tier\-1 vendor for the core control. > **Call to action:** Selecting blockchain analytics for your CASP authorisation? Finconduit makes vetted introductions to Chainalysis, Elliptic, and TRM Labs and helps scope the right architecture for your volume, asset mix, and licence class. Get a free analytics architecture review. ## Related Guides - [AML Compliance for Crypto Firms](/resources/aml-compliance-crypto-6amld): What the 6**AML**D requires from **CASP**s and **VASP**s - [MiCA Travel Rule Providers Compared](/resources/mica-travel-rule-providers-compared): **Notabene** vs **Sumsub** vs **Sygna** vs **Veriscope** - [MiCA Compliance Guide for CASPs](/resources/mica-compliance-guide-casps): Authorisation walkthrough — capital, governance, supplier stack - [How to Get a Bank Account for a VASP or CASP](/resources/bank-account-vasp-casp): The 2026 banking playbook for regulated crypto firms Blockchain analytics is the central nervous system of a regulated crypto **AML programme** — and the vendor choice has long\-tail consequences for **false\-positive rate**s, **investigation** speed, supervisory dialogue, and unit economics. Pick the provider that matches your volume tier, asset mix, and use\-case depth; assume you will move to dual coverage within 18 months of crossing €1B annual volume; and remember that the cheapest vendor at signing can be the most expensive at the operational layer if attribution is thin where your customer base actually transacts. ## Footnotes [^1]: Regulation \(EU\) 2023/1113 \(Transfer of Funds Regulation\), applicable from 30 December 2024 — extends FATF Recommendation 16 Travel Rule to crypto\-asset transfers ≥ €1,000. [^2]: EBA Guidelines on the management of money laundering and terrorist financing risks \(EBA/GL/2021/02\) — addresses crypto\-specific typologies including mixers, peel chains, and privacy coins. [^3]: Regulation \(EU\) 2023/1114 \(Markets in Crypto\-Assets Regulation — MiCA\) — authorisation files require evidence of operational blockchain analytics capability. [^4]: Office of Foreign Assets Control \(OFAC\) — administers and enforces US sanctions; OFAC SDN list applies extraterritorially to non\-US firms via secondary sanctions. [^5]: Directive \(EU\) 2018/1673 \(Sixth Anti\-Money Laundering Directive — 6AMLD\). [^6]: Regulation \(EU\) 2024/1624 \(AMLR\) — applicable from 10 July 2027 — codifies enhanced due diligence triggers including high\-risk crypto exposure. --- Source: https://finconduit.com/resources/blockchain-analytics-providers-compared